China Isotope & Radiation (HKG:1763) said it is renewing a range of agreements with China National Nuclear Corp., or CNNC, according to a Hong Kong bourse filing Thursday.
Shares of the radiopharmaceuticals firm gained over 1% in morning trade Friday.
The renewals cover existing products and services supply frameworks, leasing agreements, engineering construction services frameworks, and certain financial services frameworks.
The agreements will be renewed for a three year period ending Dec. 31, 2028.